Optimal Treatment of Helicobacter pylori With Ranitidine Bismuth Citrate (RBC): A Randomized Comparison Between Two 7-Day Triple Therapies and a 14-Day Dual Therapy-Reference-Cited by-同舟云学术

Optimal Treatment of Helicobacter pylori With Ranitidine Bismuth Citrate (RBC): A Randomized Comparison Between Two 7-Day Triple Therapies and a 14-Day Dual Therapy

Published:1998-07 Issue:7 Volume:93 Page:1101-1107
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

de Boer Wink A,Haeck Peter W E,Otten Marten H,Mulder ChrisJ J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference52 articles.

1. The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer Disease

2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

3. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antibiotic resistance onHelicobacter pylorieradication efficacy: A systematic review and meta‐analysis;Helicobacter;2020-06-12

2. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori;Alimentary Pharmacology & Therapeutics;2007-05-26

3. Systematic Review and Meta-analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication;Helicobacter;2005-06

4. One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment ofHelicobacter pyloriinfection in Brazilian patients with peptic ulcer;World Journal of Gastroenterology;2005

5. Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis;American Journal of Health-System Pharmacy;2004-03-15